Robert L Wilensky
Overview
Explore the profile of Robert L Wilensky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
5361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feldbaum E, Thompson E, Cook T, Sanghavi M, Wilensky R, Fiorilli P, et al.
Vasc Med
. 2023 Apr;
28(2):131-138.
PMID: 37025021
Background: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome. Guidance regarding the optimal management of patients with SCAD has been published over the past...
2.
Alferiev I, Chorny M, Wilensky R, Levy R, Fishbein I
Methods Mol Biol
. 2022 Aug;
2573:217-233.
PMID: 36040598
Percutaneous coronary interventions (PCI) are the mainstay for treatment of advanced coronary disease. A majority of PCI involve deployment of a stent in the affected vascular segment. This chapter introduces...
3.
Hooshdaran B, Pressly B, Alferiev I, Smith J, Zoltick P, Tschabrunn C, et al.
Sci Rep
. 2022 Apr;
12(1):5464.
PMID: 35361857
In-stent restenosis (ISR) complicates revascularization in the coronary and peripheral arteries. Apolipoprotein A1 (apoA1), the principal protein component of HDL possesses inherent anti-atherosclerotic and anti-restenotic properties. These beneficial traits are...
4.
Lu D, Steitieh D, Feldman D, Cheung J, Wong S, Halazun H, et al.
Am J Cardiol
. 2020 Mar;
125(9):1295-1304.
PMID: 32145896
Patients with cirrhosis often have concomitant coronary artery disease and require percutaneous coronary intervention (PCI). PCI in cirrhotics can be associated with significant risks due to thrombocytopenia, possible coagulopathies, bleeding,...
5.
Lu D, Saybolt M, Kiss D, Matthai W, Forde K, Giri J, et al.
Clin Med Insights Cardiol
. 2020 Feb;
14:1179546820901491.
PMID: 32030068
Background: Patients with cirrhosis and coronary artery disease (CAD) are at high risk for morbidity during surgical revascularization so they are often referred for complex percutaneous coronary intervention (PCI). Percutaneous...
6.
Tuteja S, Glick H, Matthai W, Nachamkin I, Nathan A, Monono K, et al.
Circ Genom Precis Med
. 2020 Jan;
13(1):e002640.
PMID: 31928229
Background: loss-of-function alleles impair clopidogrel effectiveness after percutaneous coronary intervention, but the clinical impact of implementing genotyping in a real-world setting is unknown. The purpose of the study was to...
7.
8.
Hyman M, Ren J, Anjan V, Wilensky R, Frankel D
JACC Clin Electrophysiol
. 2018 May;
3(4):420-421.
PMID: 29759457
No abstract available.
9.
Kobayashi T, Glorioso T, Armstrong E, Maddox T, Plomondon M, Grunwald G, et al.
JAMA Cardiol
. 2017 Jul;
2(9):967-975.
PMID: 28724126
Importance: Current comparative outcomes among black and white patients treated with percutaneous coronary intervention (PCI) in the Veterans Affairs (VA) health system are not known. Objective: To compare outcomes between...
10.
Mangels D, Giri J, Hirshfeld J, Wilensky R
Catheter Cardiovasc Interv
. 2017 Jul;
90(6):948-955.
PMID: 28722293
Performance of percutaneous coronary intervention (PCI) is associated with several occupational hazards including radiation exposure and musculoskeletal injury. Current methods to mitigate these risks range from suspended radiation suits to...